Oxygen-dependent injury by a human plasma factor associated with minimal change disease

Pediatric Nephrology

Volumn 12, Issue 6, 1998, Pages 452-458

  Cheung, Po Kam ^a   Baller, Julius F W ^a   Bakker, Winston W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

100KF; Glomerular permeability; Minimal change disease; Nephrotic syndrome; Reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALBUMIN; OXYGEN; SIALOGLYCOPROTEIN; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULOPATHY; GLOMERULUS FILTRATION; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MINIMAL BRAIN DYSFUNCTION; NONHUMAN; PLASMA FACTOR; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATASES; ALBUMINS; ANIMALS; BLOOD PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY GLOMERULUS; MOLECULAR WEIGHT; NEPHROSIS, LIPOID; OXYGEN; RATS; RATS, WISTAR; SERINE ENDOPEPTIDASES; SIALOGLYCOPROTEINS; SUPEROXIDE DISMUTASE;

EID: 0031855503     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050486     Document Type: Article

References (45)

1. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF (1972) Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 773:343-348
2. Ramos EL (1991) Recurrent diseases in the renal allograft. J Am Soc Nephrol 2:109-121
3. Savin VJ (1993) Mechanisms of proteinuria in noninflammatory glomerular diseases. Am J Kidney Dis 21:347-362
4. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jaques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soullilou JP (1994) Effect of plasma protein absorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7-14
5. Levin M, Smith C, Walters MDS, Gascoine P, Turner MW, Barratt TM (1985) Steroid responsive nephrotic syndrome, a generalized disorder of membrane negative charge. Lancet II:239-242
6. Ghiggeri GM, Ginevri F, Candiano G, Oleggini R, Perfumo F, Queirolo C, Gusmano R (1987) Characterization of cationic albumin in minimal change nephropathy. Kidney Int 32:547-553
7. Lagrue G, Xheneumont S, Branellec A, Hirbec G, Weil B (1975) A vascular permeability factor elaborated from lymphocytes. Demonstration in patients with nephrotic syndrome. Biomedicine 23:37-49
8. Boulton-Jones JM, Tullock I, Dore B, Mclay A (1983) Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol 20: 72-77
9. Bakker WW, Beukhof JR, Luijk WHJ van, Hem GK van der (1982) Vascular permeability increasing factor (VPF) in IgA nephropathy. Clin Nephrol 18:165-267
10. Tomizawa S, Maruyama K, Nagasawa N, Suzuki S, Kuroume T (1985) Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome. Nephron 41: 157-160
11. Tanaka R, Yoshikawa N, Nakamura H, Ito H (1992) Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats. Nephron 60:35-41
12. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M (1991) A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40:453-460
13. Wilkinson A, Williams DG, Gillespie C, Hartley B (1986) Nephrotic plasma increases proteinuria and reduced anionic sites on the glomerular basement membrane in vivo in NZW rabbits. Kidney Int 29:295
14. Thomson NM, Kraft N (1987) Normal human serum also contains the lymphotoxin found in minimal change nephropathy. Kidney Int 31:1186-1193
15. Bakker WW, Luijk WHJ van (1989) Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome. Pediatr Nephrol 3:341-349
16. Zimmerman SW (1984) Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol 20:72-77
17. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883
18. Bakker WW, Baller JFW, Luijk WHJ van (1988) A kallikreinlike molecule and plasma vasoactivity in minimal change disease. Contrib Nephrol 67:31-36
19. Cheung PK, Boes A, Dijkhuis FWJ, Klok PA, Bakker WW (1995) Enhanced glomerular permeability and minimal change disease like alterations of the rat kidney induced by a vasoactive human plasma factor. Kidney Int 47:1218
20. Cheung PK, Klok PA, Bakker WW (1996) Minimal change-like glomerular alterations induced by a human plasma factor. Nephron 74:586-593
21. Cheung PK, Baller JFW, Bakker WW (1996) Impairment of endothelial and subendothelial sites by a circulating plasma factor associated with minimal change disease. Nephron Dial Transplant 11:2185-2191
22. Vernier RL (1987) Primary (idopathic) nephrotic syndrome. In: Holliday MA, Barratt TM, Vernier RL (eds) Paediatric nephrology. Williams and Wilkins, Baltimore, pp 445-456
23. Cheung PK, Strate BWA van der, Bakker WW (1995) Toxic oxygen products generated in inflammtory cells by a human plasma factor involved in minimal change disease. J Am Soc Nephrol 6:415
24. Poelstra K, Hardonk MJ, Bakker WW (1988) Adriamycin induced decrease of ATPase activity in the glomerular basement membrane of the rat kidney is mediated by oxygen free radical species. In: Gubler MC, Sternberg M (eds) Progress in base-ment membrane research, renal and related aspects in health and disease. Libbey Eurotext, London, pp 259-264
25. Wachstein M, Meissel E (1957) Histochemistry of hepatic phosphatases at a physiologic pH, with special references to the demonstration of bile canaliculi. Am J Clin Pathol 27:13-16
26. Blau EB, Haas JE (1973) Glomerular sialic acid and proteinuria in human renal disease. Lab Invest 28:477-482
27. Mohos SC, Skoza L (1971) Histochemical demonstration and localization of sialoproteins in the glomerulus. Exp Mol Pathol 12:316-323
28. Hoyer JR, Mauer SM, Michael AF (1975) Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features for the experimental model produced by renal perfusion with aminonucleoside. J Lab Clin Med 85:756-768
29. Spargo BH, Taylor JR (1988) The kidney. In: Rubin E, Farber JL (eds) Pathology. Lippincott, Philadelphia, pp 832-890
30. Kitano Y, Yoshikawa N, Nakamura H (1993) Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Clin Nephrol 40:199-204
31. Stow JL, Sawada H, Farquhar MG (1985) Basement membrane heparan sulphate proteoglycans are concentrated in the laminae rarae and in podocytes of the rat renal glomerulus. Proc Natl Acad Sci USA 82:3296-3300
32. Bakker WW, Kalicharan D, Donga J, Hulstaert CE, Hardonk MJ (1987) Decreased ATPase activity in adriamycin nephrosis rat is independent of proteinuria. Kidney Int 31:704-709
33. Bakker WW, Poelstra K, Hardonk MJ (1993) Relevance of adenine nucleotidases in the glomerular filtration barrier. Nephron 64:338-342
34. Lovett DH, Johnson RT, Murti HP, Martin J, Davies M, Couser WG (1992) Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 141:85-98
35. Sterzel RB, Schulze-Lohoff E, Marx M (1993) Cytokines and menangial cells. Kidney Int 43 Suppl] 39:S26-S31
36. Fantone JC, Ward PA (1982) Role of oxygen-derived free radicals and metabolites in leukocyte dependent inflammatory reactions. Am J Pathol 397:397-418
37. Donovan KL, Davies M, Coles GA, Williams JD (1994) Relative roles of elastase and reactive oxygen species in the degradation of human glomerular basement membrane by intact human neutrophils. Kidney Int 45:1555-1561
38. Kozin F, Cochrane CG (1992) The contact activation system of plasma; biochemistry and pathophysiology. In: Gallin JI, Goldstein JM, Snyderman R (eds) Inflammation basic principles and clinical correlates, Raven, New York, pp 103-121
39. Diamond JR (1992) The role of reactive oxygen species in animal models of glomerular disease. Am J Kidney Dis 19: 292-300
40. Baud L, Ardaillou R (1993) Involvement of reactive oxygen species in kidney damage. Br Med Bull 49:621-629
41. Baud L, Fouqueray B, Philippe C, Ardaillou R (1992) Reactive oxygen species as glomerular autacoids. J Am Soc Nephrol 2:132-138
42. Ichikawa I, Kiyama S, Yoshioka T (1994) Renal antioxidant enzymes: their regulation and function. Kidney Int 45:1-9
43. Bakker WW, Willink EJ, Donga J, Hulstaert CE, Hardonk MJ (1987) Antithrombotic activity of glomerular adenosine diphosphatase in the glomerular basement membrane of the rat kidney. J Lab Clin Med 109:171-177
44. Cheung PK, Klok PA, Bakker WW (1997) Induction of experimental proteinuria in vivo following infusion of a human plasma factor associated with minimal change disease (MCD). Kidney Int 52:562
45. Cheung PK, Baller JFW, Horst MLC van der, Bakker WW (1997) Expression of glomerular ecto-ATPase in idiopathic nephrotic syndrome. In: Plesner L, Kirley TE, Knowles AF (eds) Proceedings of the First International workshop on ecto-ATPase. Plenum, New York, pp 187-196